NASDAQ:DRAD - Digirad Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $6.00
  • Forecasted Upside: 117.39 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$2.76
▲ +0.1 (3.76%)
Get New Digirad Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for DRAD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for DRAD

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$6.00
▲ +117.39% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Digirad in the last 3 months. The average price target is $6.00, with a high forecast of $6.00 and a low forecast of $6.00. The average price target represents a 117.39% upside from the last price of $2.76.
Buy
The current consensus among 1 polled investment analysts is to buy stock in Digirad.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/29/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/27/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/25/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/23/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/21/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/22/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/25/2020Maxim GroupInitiated CoverageBuy$6.00High
i
10/5/2017B. RileyReiterated RatingBuy$60.00N/A
i
8/5/2017B. RileyReiterated RatingBuy$64.00High
i
7/31/2017B. RileyReiterated RatingBuy$64.00Low
i
5/1/2017B. RileyReiterated RatingBuy$64.00Low
i
4/26/2017B. RileyReiterated RatingBuy$67.00High
i
2/26/2017B. RileyReiterated RatingBuy$67.00N/A
i
2/21/2017B. RileyReiterated RatingBuy$67.00N/A
i
11/1/2016B. RileyReiterated RatingBuy$67.00N/A
i
10/27/2016B. RileyReiterated RatingBuy$70.00N/A
i
9/11/2016B. RileyReiterated RatingBuy$70.00N/A
i
9/6/2016B. RileyReiterated RatingBuy$70.00N/A
i
Rating by A. D'silva at B. Riley
7/31/2016B. RileyReiterated RatingBuy$70.00N/A
i
7/26/2016B. RileyReiterated RatingBuy$70.00N/A
i
5/25/2016SidotiInitiated CoverageBuy$80.00N/A
i
5/1/2016B. RileyReiterated RatingBuy$70.00N/A
i
4/26/2016B. RileyReiterated RatingBuy$70.00N/A
i
(Data available from 4/21/2016 forward)
Digirad logo
Digirad Corporation provides healthcare solutions in the United States and internationally. It operates through five segments: Diagnostic Services, Diagnostic Imaging, Mobile Healthcare, Building and Construction, and Real Estate and Investments. The company offers imaging and monitoring services to healthcare providers; and contract diagnostic imaging, including computerized tomography (CT), magnetic resonance imaging, positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to hospitals, integrated delivery networks, and federal institutions on a long-term contract basis, as well as provisional services to institutions that are in transition. It also develops, sells, and maintains solid-state gamma cameras, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance contract services. In addition, it manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; and manages real estate assets and investments. Digirad Corporation was founded in 1985 and is headquartered in Suwanee, Georgia.
Read More

Today's Range

Now: $2.76
$2.67
$2.79

50 Day Range

MA: $3.58
$2.79
$4.65

52 Week Range

Now: $2.76
$1.99
$8.84

Volume

242,186 shs

Average Volume

485,592 shs

Market Capitalization

$13.14 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.18

Frequently Asked Questions

What sell-side analysts currently cover shares of Digirad?

The following Wall Street sell-side analysts have issued reports on Digirad in the last year: Maxim Group.
View the latest analyst ratings for DRAD.

What is the current price target for Digirad?

1 Wall Street analysts have set twelve-month price targets for Digirad in the last year. Their average twelve-month price target is $6.00, suggesting a possible upside of 117.4%. Maxim Group has the highest price target set, predicting DRAD will reach $6.00 in the next twelve months. Maxim Group has the lowest price target set, forecasting a price of $6.00 for Digirad in the next year.
View the latest price targets for DRAD.

What is the current consensus analyst rating for Digirad?

Digirad currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe DRAD will outperform the market and that investors should add to their positions of Digirad.
View the latest ratings for DRAD.

What other companies compete with Digirad?

How do I contact Digirad's investor relations team?

Digirad's physical mailing address is 1048 INDUSTRIAL COURT, SUWANEE GA, 92064. The medical equipment provider's listed phone number is 858-726-1600 and its investor relations email address is [email protected] The official website for Digirad is www.digirad.com.